Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for highly accurate and efficient testing of complex and infectious diseases for human and animal health. Pictor's PictArray™ multiplexed technology makes it possible to test multiple disease markers in a single test simultaneously – with higher sensitivity, faster throughput, and reduced turn-around time. The company’s lead product, PictArray™ SARS-CoV-2 IgG ELISA Kit, enables more informed clinical interventions to reduce the threat of COVID-19.
Pictor partners with Mobility Health, USA, to launch the PictArray™ SARS-CoV-2 Antibody Test on the US Market
Pictor’s multiplex platform allows multiple analytes to be detected in one test. This has been applied in the PictArrayTM SARS-CoV-2 ELISA Test to detect IgG antibodies to both the Spike Protein and Nucleocapsid Protein in a single test leading to better health outcomes through earlier diagnosis, prevention and treatment.
News
Read the latest News, Articles and Publications
English (New Zealand) 
English 
हिन्दी